Baby due as a result of first ever whole ovary transplant



Researchers led by Drs. Lillian Maggio-Price and Brian Iritani at The University of Washington found that mice that lack the immune inhibitory molecule Smad3 are acutely sensitive to both bacterially-induced inflammation and cancer. They report these findings in the January 2009 issue of The American Journal of Pathology. Bacteria contribute to the development of certain

Full Post: Inflammation contributes to colon cancer

In what is thought to be a world-first, a British woman who was given an ovary transplant is about to give birth to her first baby.

The 38-year-old Londoner underwent the pioneering whole ovary transplant in the U.S. early last year when her identical twin sister’s donated ovary was transplanted after being removed using keyhole surgery.

The transplant was carried out by Dr. Sherman Silber and his team at the Infertility Centre of St Louis in Missouri and is the first to result in a successful pregnancy.

The woman’s ovaries stopped working when she was 15, when she experienced a premature menopause and stopped producing hormones and she has become pregnant a year after receiving her sister’s ovary.

According to Dr. Silber identical twins are five times more likely than the rest of the female population to suffer ovary damage and his pioneering new procedure is particularly relevant for them.

As the twins are genetically identical, eggs from the donor ovary are equivalent to those produced by the patient herself - women who are not genetically identical produce genetically different eggs so the transplant technique will have limited application for women who are not twins.

However it does offer the possibility of removing and freezing an ovary prior to cancer treatment such as radiotherapy and chemotherapy.

The transplantation of the walnut-sized ovary demanded microsurgery to reconnect blood vessels as small as half a millimeter in diameter and follows previous successes by the team with ovary graft transplants, where a slice of ovary tissue is grafted onto an infertile patient’s own ovary.

The first graft transplant to produce a successful pregnancy was in 2004 and was also between twin sisters.

Dr. Silber says reconnecting such blood vessels deep inside the pelvis can be a tactical challenge and is an extremely delicate procedure as the ovarian artery is less than a third of a millimetre in diameter.

Three months following the surgery, the London patient had her first period in 22 years, showing that she was ovulating normally again - Dr. Silber says they believe this is the first successful human intact whole ovary transplant which has led to healthy pregnancy.

Dr. Silber and his team have also tested techniques for freezing ovaries for future transplant and have successfully preserved 27 ovaries, and also for the first time five fallopian tubes and he says their work represents a new chapter in reproductive organ transplantation.

He says as well as whole ovary transplantation it is now possible to consider fallopian tube transplant for women with irreparable tubal disease.

Dr. Silber will present his research results this week at the American Society of Reproductive Medicine’s annual meeting in San Francisco.

Link




Scientists at the Centre for Addiction and Mental Health (CAMH) have detected evidence that DNA may not be the only carrier of heritable information; a secondary molecular mechanism called epigenetics may also account for some inherited traits and diseases. These findings challenge the fundamental principles of genetics and inheritance, and potentially provide a new insight

Full Post: Epigenetics may account for some inherited traits and diseases



A unique approach to bone marrow transplantation pioneered in part by a Children’s Hospital of Pittsburgh of UPMC physician has proven to be the only safe and effective cure for sickle cell disease, according to a new study. Lakshmanan Krishnamurti, MD, a pediatric hematologist/oncologist at Children’s Hospital, helped pioneer a form of bone marrow transplantation

Full Post: New approach to bone marrow transplantation found to be a safe and effective cure for sickle cell disease



A Johns Hopkins transplant surgeon has found strong evidence that women over 45 are significantly less likely to be placed on a kidney transplant list than their equivalent male counterparts, even though women who receive a transplant stand an equal chance of survival. “As woman age, that discrepancy widens to the point where woman over

Full Post: Older women less likely than men to be listed on a kidney transplant list



Schering-Plough Corp. has announced that the European Medicines Agency (EMEA) has validated (accepted for review) its Marketing Authorization Application (MAA) for corifollitropin alfa, the company’s experimental, sustained follicle stimulant (SFS). This application will follow the Centralized Procedure. Corifollitropin alfa is being developed as a potential treatment in Controlled Ovarian Stimulation (COS) for the development of

Full Post: Schering-Plough announces European submission of fertility medicine Corifollitropin Alfa



Researchers in the U.S. have discovered a new cancer drug which effectively treats transplant rejections. The researchers from the University of Cincinnati (UC) say the new therapy for transplant patients, targets the antibody-producing plasma cells that can cause organ rejection. According to a study by Dr. Steve Woodle and colleagues, the cancer drug bortezomib which

Full Post: New therapy for transplant rejection